17 Mar Iluvien: New Drug for Diabetic Macular Edema
Iluvien, an injectable drug delivery system, gets one step closer to be the first drug FDA approved for the treatment of diabetic macular edema....
alimera Tag
05 Jan 2010: "Year of the…Drug Delivery System?"
Ophthalmic drug delivery is changing with sustained release technology. Icon Biosciences, Inc., announces their intent to test a new anti-inflammatory extended release eye product. ...
28 Dec Iluvien® For Diabetic Macular Edema Has Eyes on FDA
Alimera's Iluvien proving effective in phase 3 clinical trials. Iluvien will release fluocinolone acetonide for the treatment of diabetic macular edema. Iluvien is an injectable extended release delivery system....
08 Oct SurModics' Drug Delivery to Release Lucentis for Macular Degeneration
Surmodics announces agreement with Genentech/Roche to combine proprietary drug delivery system with Lucentis (ranibizumab) for the treatment of wet macular degeneration....
02 Oct Intraocular Drug System Passing FDA Testing
Alimera Sciences announces positive results on Iluvien. Phase 2 clinical trial data is promising....
29 Sep Intraocular Drug Delivery – It's About Timing
Intraocular drug delivery systems are just emerging and the timing couldn't better....
28 Sep Company Hopes Injectable Implant Cures Diabetic Macular Edema
Intraocular drug delivery systems are developing to treat diabetic macular edema. Sustained release systems offer hope of long term treatment, compliance and little or no side effects....